Exclusive extracts from this 26-page-long report:
- Who is the player?
Johnson & Johnson is an American multinational company founded in 1886 and specialised in the health care market. As of December 31, 2017, the company operated through 260 subsidiaries, located all over the world. [...]
- What are the player's strategies?
The American company has mainly focused its strategy on fast-growing segments, such as the eye care, software-enabled and robotic-assisted solutions for surgeons, with the acquisition of specialised companies, including Orthaxy, Surgical Process Institute and Sentio, Sightbox and Tearscience. In 2017, the company completed 17 acquisitions and licensing agreements, for a total investment of around €31.2 billion in M&A. […]
- What are the player's strengths and weaknesses?
Wide geographical presence, since Johnson & Johnson operated in more than 60 countries around the world in 2017.
Large production and distribution network, with 260 subsidiaries located all around the world.[…]
Strong decline in net income, which experienced a 92.1% decrease between 2016 and 2017, mostly due to rising income taxes.
Strong reliance on the domestic US market, which accounted for 52.1% of the company's total revenue in 2017. […]
- What is the player's financial position?
The financial indicators included in the report include: Consolidated net revenues, Consolidated operating income and margin, Consolidated net profit and margin, R&D expenses, Sales by segment, Sales performance by segment, Sales by region, Sales performance by region, Profitability ratios, Liquidity ratios, Solvency ratios and Free cash flow and capital expenditure.